Log in

NYSE:USPHU.S. Physical Therapy Stock Price, Forecast & News

$77.74
+2.77 (+3.69 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
$76.51
Now: $77.74
$79.42
50-Day Range
$56.57
MA: $70.08
$75.75
52-Week Range
$45.13
Now: $77.74
$148.48
Volume119,763 shs
Average Volume142,228 shs
Market Capitalization$998.49 million
P/E Ratio34.40
Dividend Yield1.71%
Beta1.28
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors As of March 14, 2019, it operated 592 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.
Read More
U.S. Physical Therapy logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.0Dividend Strength: 4.2Insider Behavior: 3.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.84 out of 5 stars


Industry, Sector and Symbol

Industry Health services
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP90337L10
Phone713-297-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$481.97 million
Cash Flow$3.74 per share
Book Value$18.92 per share

Profitability

Net Income$40.04 million

Miscellaneous

Employees5,400
Market Cap$998.49 million
Next Earnings Date8/13/2020 (Estimated)
OptionableOptionable

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.

U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

How has U.S. Physical Therapy's stock been impacted by COVID-19 (Coronavirus)?

U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, USPH shares have decreased by 16.6% and is now trading at $77.74. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of U.S. Physical Therapy?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for U.S. Physical Therapy.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for U.S. Physical Therapy.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) posted its quarterly earnings results on Thursday, May, 21st. The company reported $0.30 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.37 by $0.07. The company earned $112.70 million during the quarter, compared to analysts' expectations of $101.89 million. U.S. Physical Therapy had a net margin of 6.17% and a return on equity of 13.48%. U.S. Physical Therapy's quarterly revenue was down 3.0% on a year-over-year basis. During the same period last year, the company earned $0.66 EPS. View U.S. Physical Therapy's earnings history.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Friday, February 28th. Shareholders of record on Friday, March 13th will be given a dividend of $0.32 per share on Friday, April 17th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date is Thursday, March 12th. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.30. View U.S. Physical Therapy's dividend history.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy updated its FY 2020 Pre-Market earnings guidance on Thursday, February, 27th. The company provided earnings per share guidance of 2.98-3.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.15.

What price target have analysts set for USPH?

3 brokers have issued 1-year price targets for U.S. Physical Therapy's stock. Their forecasts range from $80.00 to $120.00. On average, they expect U.S. Physical Therapy's stock price to reach $100.00 in the next twelve months. This suggests a possible upside of 28.6% from the stock's current price. View analysts' price targets for U.S. Physical Therapy.

Has U.S. Physical Therapy been receiving favorable news coverage?

Press coverage about USPH stock has trended negative this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. U.S. Physical Therapy earned a media sentiment score of -2.6 on InfoTrie's scale. They also gave news articles about the company a news buzz of 9.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. View the latest news aboutU.S. Physical Therapy.

Are investors shorting U.S. Physical Therapy?

U.S. Physical Therapy saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 1,110,000 shares, an increase of 7.8% from the April 30th total of 1,030,000 shares. Based on an average daily trading volume, of 165,300 shares, the days-to-cover ratio is currently 6.7 days. Currently, 8.8% of the company's shares are sold short. View U.S. Physical Therapy's Current Options Chain.

Who are some of U.S. Physical Therapy's key competitors?

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), Marathon Petroleum (MPC), Royal Caribbean Cruises (RCL), Starbucks (SBUX), AbbVie (ABBV), Carnival (CCL), Gilead Sciences (GILD), IBM (IBM), Lowe's Companies (LOW) and AT&T (T).

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the following people:
  • Mr. Christopher J. Reading, Pres, CEO & Director (Age 55)
  • Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 64)
  • Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 62)
  • Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 55)
  • Mr. Jon C. Bates, VP & Corp. Controller

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (17.26%), Fred Alger Management LLC (4.10%), State Street Corp (3.39%), Riverbridge Partners LLC (2.90%), Copeland Capital Management LLC (2.31%) and Wasatch Advisors Inc. (2.26%). Company insiders that own U.S. Physical Therapy stock include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Jerald L Pullins, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson. View institutional ownership trends for U.S. Physical Therapy.

Which institutional investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Blair William & Co. IL, Invesco Ltd., First Trust Advisors LP, WINTON GROUP Ltd, UBS Group AG, Schroder Investment Management Group, KBC Group NV, and Russell Investments Group Ltd.. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Lawrance W Mcafee, and Mark J Brookner. View insider buying and selling activity for U.S. Physical Therapy.

Which institutional investors are buying U.S. Physical Therapy stock?

USPH stock was acquired by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Fred Alger Management LLC, Copeland Capital Management LLC, Morgan Stanley, Morgan Stanley, Bahl & Gaynor Inc., JPMorgan Chase & Co., and BlackRock Inc.. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin, and Regg E Swanson. View insider buying and selling activity for U.S. Physical Therapy.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $77.74.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $998.49 million and generates $481.97 million in revenue each year. The company earns $40.04 million in net income (profit) each year or $2.82 on an earnings per share basis. U.S. Physical Therapy employs 5,400 workers across the globe.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is www.usph.com.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.